| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO A USD DIS | RVI JAPÓN | 19,45% | 40,02% | 26,97% | 110,57% |
| PICTET - ASIAN EQUITIES EX JAPAN P DY USD | RVI ASIA EX-JAPÓN | 34,88% | · | 26,97% | 119,23% |
| ALLIANZ STRATEGY 50 AT (H-USD) CAP | MIXTO MODERADO GLOBAL | 10,52% | 21,30% | 26,96% | · |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES E2 JPY | RVI JAPÓN SMALL/MID CAP | 19,02% | 58,73% | 26,96% | 98,80% |
| GOLDMAN SACHS ASIA EQUITY PORTFOLIO R GBP DIS | RVI ASIA EX-JAPÓN | 32,29% | 57,79% | 26,96% | 113,00% |
| CARMIGNAC PORTFOLIO EMERGING PATRIMOINE A CHF ACC HGD | MIXTO MODERADO GLOBAL | 14,00% | 23,39% | 26,95% | 62,08% |
| IMGP US VALUE C EUR | RVI USA VALOR | 2,33% | 11,24% | 26,95% | · |
| RAIFFEISEN-ASIA-OPPORTUNITIES-ESG-AKTIEN (R) (A) | RVI EMERGENTES | 38,07% | 64,13% | 26,95% | 59,77% |
| UBS (LUX) BOND SICAV - CONVERT GLOBAL (EUR) (USD HEDGED) Q-ACC | RF EURO CONVERTIBLES | 13,72% | 29,33% | 26,95% | 106,55% |
| XTRACKERS MSCI WORLD HEALTH CARE UCITS ETF 1C | RVI SALUD | 20,14% | 15,95% | 26,95% | 125,04% |
| DWS ESG BIOTECH TFC | RVI BIOTECNOLOGÍA | 36,15% | 37,36% | 26,94% | · |
| GOLDMAN SACHS EMERGING MARKETS EQUITY ESG PORTFOLIO P USD CAP | RVI EMERGENTES | 33,62% | 69,49% | 26,94% | · |
| SCHRODER ISF EMERGING MARKETS A ACC EUR (HEDGED) | RVI EMERGENTES | 30,41% | 79,98% | 26,94% | 91,23% |
| SALAR E1 GBP DIS INCOME | RFI GLOBAL CONVERTIBLES | 8,28% | 25,23% | 26,93% | 50,59% |
| TEMPLETON EMERGING MARKETS BOND A (ACC) USD | RFI EMERGENTES | 14,42% | 34,92% | 26,93% | 19,59% |
| T.ROWE GLOBAL GROWTH EQUITY FUND I | RVI GLOBAL CRECIMIENTO | 15,70% | 49,40% | 26,92% | 219,35% |
| WELLINGTON US$ CORE HIGH YIELD BOND FUND USD S ACC | RFI USA HIGH YIELD | 5,84% | 16,86% | 26,92% | · |
| BNP PARIBAS EURO EQUITY N EUR CAP | RV EURO CRECIMIENTO | 12,80% | 28,54% | 26,91% | 88,42% |
| INVESCO ASIA OPPORTUNITIES EQUITY E CAP EUR | RVI ASIA EX-JAPÓN | 23,84% | 54,52% | 26,91% | 74,63% |
| BNP PARIBAS GLOBAL MEGATRENDS CLASSIC USD DIS | RVI GLOBAL | 9,75% | 37,87% | 26,90% | · |
